Advertisement

Topics

Cytopia Limited Company Profile

00:03 EST 19th November 2017 | BioPortfolio

Cytopia aims to identify new candidate therapeutics (drug leads) for asthma and a range of inflammatory diseases. Many current drugs have significant side effects such as gastric upsets and ulcers and Cytopia's technology has the potential to discover more specific drugs without these side effects.

Cytopia has an exclusive, worldwide royalty-free license to commercially exploit technology developed by its Research Director, Dr Andrew Wilks, whilst at the Ludwig Institute for Cancer Research in Melbourne.



Licensed patents give Cytopia sole right to commercially exploit several genes and protein (known as JAK kinases) which play a crucial role in controlling the inflammatory process, for example in rheumatoid arthritis.



Cytopia is developing technology which allows large chemical collections to be tested for their ability to inhibit the activity of the patented proteins. Chemicals which are specifically active may be able to prevent certain inflammatory diseases.

Location

41, Victoria Parade
Fitzroy
Victoria
3065
Australia

Contact

Phone: (613) 9288 2973
Fax: 613 9288 2013
Email: cytopia@cytopia.com.au


News Articles [19 Associated News Articles listed on BioPortfolio]

Implicit Bioscience: Accelerating Value Creation in Biotech Firms

Fintan Walton talks to Dick Haiduck about his work with Implicit Bioscience, Cytopia and others, and his ‘partner to CEO’ service. Dick describes these two different companies - both based in Aust...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [84 Associated Companies listed on BioPortfolio]

Cytopia Ltd.

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and drug development through...

Cytopia

Cytopia's mission is to become a leading discoverer of targeted small molecule therapeutics for diseases such as cancer, cardiovascular and immune disease, delivering drug candidates at various stages...

Cytopia Limited

Cytopia aims to identify new candidate therapeutics (drug leads) for asthma and a range of inflammatory diseases. Many current drugs have significant side effects such as gastric upsets and ulcers and...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Cytopia Limited" on BioPortfolio

We have published hundreds of Cytopia Limited news stories on BioPortfolio along with dozens of Cytopia Limited Clinical Trials and PubMed Articles about Cytopia Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cytopia Limited Companies in our database. You can also find out about relevant Cytopia Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record